Summary
Characterised lead candidates will be expressed and antibody purified for the direct passive therapy in preclinical studies Sufficient purified antibodyprotein will be generated to ensure full preclinical studies can be performed
More information & hyperlinks
Search
Associated projects
Associated products/services
- No items published